![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 10, 6385-6394, March 10, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-(1,3/1,4)-Fucosyltransferases*



1
2
From the
Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2H7 and the
Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada
The minimal catalytic domain of
-(1,3/1,4)-fucosyltransferases (FucTs) from Helicobacter pylori strains NCTC11639 and UA948 was mapped by N- and C-terminal truncations. Only the C terminus could be truncated without significant loss of activity. 11639FucT and UA948FucT contain 10 and 8 heptad repeats, respectively, which connect the catalytic domain with the C-terminal putative amphipathic
-helices. Deletion of all heptad repeats almost completely abolished enzyme activity. Nevertheless, with only one heptad repeat 11639FucT is fully active, whereas UA948FucT is partially active. Removal of the two putative amphipathic
-helices dramatically increased protein expression and solubility, enabling purification with yields of milligrams/liter. Steady-state kinetic analysis of the purified FucTs showed that 11639FucTs possessed slightly tighter binding affinity for both Type II acceptor and GDP-fucose donor than UA948FucT, and its kcat of 2.3 s-1 was double that of UA948FucT, which had a kcat value of 1.1 s-1 for both Type II and Type I acceptors. UA948FucT strongly favors Type II over the Type I acceptor with a 20-fold difference in acceptor Km. Sixteen modified Type I and Type II series acceptors were employed to map the molecular determinants of acceptors required for recognition by H. pylori
-(1,3/1,4)-FucTs. Deoxygenation at 6-C of the galactose in Type II acceptor caused a 5000-fold decrease in
1,3 activity, whereas in Type I acceptor this completely abolished
1,4 activity, indicating that this hydroxyl group is a key polar group.
Received for publication, October 18, 2005 , and in revised form, December 21, 2005.
* This work was supported by grants from the Canadian Bacterial Diseases Network Center of Excellence Program (to D. E. T.), the National Sciences and Engineering Research Council, and the Alberta Ingenuity Center for Carbohydrate Science (to M. M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains two supplemental tables.
1 Scholar of the Alberta Heritage Foundation for Medical Research.
2 To whom correspondence should be addressed: Dept. of Medical Microbiology and Immunology, 1-63 Medical Sciences Bldg., University of Alberta, Edmonton, Alberta T6G 2H7, Canada. Tel.: 780-492-4777; Fax: 780-492-7521; E-mail: diane.taylor{at}ualberta.ca.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H.-Y. Sun, S.-W. Lin, T.-P. Ko, J.-F. Pan, C.-L. Liu, C.-N. Lin, A. H.-J. Wang, and C.-H. Lin Structure and Mechanism of Helicobacter pylori Fucosyltransferase: A BASIS FOR LIPOPOLYSACCHARIDE VARIATION AND INHIBITOR DESIGN J. Biol. Chem., March 30, 2007; 282(13): 9973 - 9982. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ma, J. L. Simala-Grant, and D. E. Taylor Fucosylation in prokaryotes and eukaryotes Glycobiology, December 1, 2006; 16(12): 158R - 184R. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |